Matrix metal proteinase-2 polypeptide inhibitors and application thereof

A peptide inhibitor and matrix metal technology, applied in the field of matrix metalloproteinase-2 peptides, can solve the problems of side effects, lack of specificity of small molecule inhibitors, etc.

Active Publication Date: 2013-08-21
NANTONG GUANGTAI BIOCHEM PROD
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Many successful small molecule inhibitors, such as Marimastat, can inhibit the activity of matrix metalloproteinases at the nanomolar level, but small molecule inhibitors lack specificity. produce side effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Matrix metal proteinase-2 polypeptide inhibitors and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] Polypeptide chemical synthesis method

[0019] Polypeptides are synthesized by Fmoc chemical method. The synthesis reaction proceeds from the C-terminus to the N-terminus. The Rink medium (available from Advanced ChemTech) has free amino groups and is connected to Thr, His, Ser, Phe, Asn and Asp in sequence. In each step of the connection process, the amino acid residues must be activated. The activation mixture contains 4 times the free amino groups on the medium of HBTU, HOBt, DIEA and Fmoc-amino acids. After each amino acid ligation reaction, a mixture of pyridine / acetic acid / N-methylimidazole (4:1:0.5) was used to block the unlinked free amino groups, and the blocking reaction was 10 minutes. After each amino acid ligation reaction, before the next amino acid is ligated, the Fmoc- group on the medium must be removed. To remove the Fmoc- group, use 20% piperidine-containing dimethylformamide, which takes 15 minutes. Finally, when all the amino acid residues are connec...

Embodiment 2

[0023] Peptide inhibitors have IC50 values ​​for several target enzymes in vitro: matrix metalloproteinase-3, -8, -2 and tumor necrosis factor releasing enzyme (both purchased from sigma).

[0024] Recombinant human matrix metalloproteinase-2 is expressed in E. coli cells. The enzyme is activated with 0.01 μM matrix metalloproteinase-3 active site. The buffer used is 100 mM Tris / HCl, pH 7.4, 100 mM NaCl, 10 mM CaCl 2 and 0.01% Tween-20. The concentration of MMP-2 during activation is 72 ng / μl (1 μM). The enzyme activity is detected by cutting the fluorescence to produce the peptide substrate Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH 2 And detection of the generated fluorescence value is achieved (excitation wavelength = 328 nm, detection wavelength = 392 nm). All detections are performed in a 100 μl reaction system at 37°C. The measured IC50 value is 42.99 μmol.

[0025] The detection of recombinant human matrix metalloproteinase-8 is similar to that of -2 and uses the same fluorescen...

Embodiment 3

[0029] Using endotoxin shock model to detect the in vivo activity of peptide inhibitors

[0030] Before establishing the endotoxin shock model, we first determined the LD50 of LPS (E. coli 0111: B4) mice as 50 μg per mouse. In the experiment, we used 100 μg per mouse. In this way, the control group All of the mice can die. A positive control experiment was done with Regasepin2. The mice in the control group were injected with 100 μg LPS, while the mice in the Regasepin2 experimental group were injected with 0.7 mg of polypeptide 5 minutes after the LPS injection. By creating a Kaplan-Meier survival curve, we found that Regasepin2 can effectively protect mice injected with 100 μg and improve the survival rate. After successfully establishing an endotoxin shock model in mice, the model was used to test the vitality of Asp-Asn-Phe-Ser-His-Thr in vivo. The mice in the control group (12 mice) were injected with 100 μg LPS, and the mice in the peptide inhibitor group (12 mice) were ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to matrix metal proteinase-2 polypeptide inhibitors and application thereof. The invention relates to the field of medicine, and particularly relates to polypeptides capable of inhibiting matrix metal proteinase-2 and tumor necrosis factor liberase and relieving damage of acute inflammation response on organisms. The sequence of the polypeptide is Asp-Asn-Phe-Ser-His-Thr which is a brand-new sequence. The inhibitors can inhibit the activities of the matrix metal proteinase-2 and tumor necrosis factor liberase in vitro on the 1 micromole level, and increase the survival rate of endotoxin shock mice in an in-vivo test, thereby having potential new drug development value.

Description

technical field [0001] The invention relates to a matrix metalloproteinase-2 polypeptide and its application, in particular to a polypeptide capable of inhibiting matrix metalloproteinase-2 and reducing acute inflammatory response damage to the body. [0002] Background technique [0003] Sepsis has always been a serious medical problem. Early sepsis without timely and effective treatment can progress to severe sepsis and septic shock, with mortality rates of 20%-30% and 40%-70%, respectively. The medical field has been researching effective treatment methods, such as early symptomatic treatment, activated protein C, corticosteroid treatment and so on. In recent years, with the deepening of medical research, great progress has been made in the understanding and treatment of sepsis. Among them, matrix metalloproteinase-2 (MMP-2) plays an important role in endotoxin shock. [0004] Matrix metalloproteinases are a group of more than 20 structurally similar and functionally...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07K7/06A61K38/08A61P29/00
Inventor 罗瑞雪
Owner NANTONG GUANGTAI BIOCHEM PROD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap